Brain training game aims to restore sight after stroke

NCT ID NCT06578117

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: University of Rochester Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new computer-based visual training task for people who have lost part of their vision due to a stroke. Participants watch moving patterns on a screen and learn to detect motion direction, with the goal of improving visual abilities. The study first checks if the training works in healthy people, then tests it in 30 stroke survivors to see if their damaged brains can still learn this way.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Vision training and learning task (computer-based motion discrimination)
What this could lead to: If successful, this could point toward a new, low-burden training method to help restore some visual abilities in people with stroke-related vision loss.
What could go wrong: This is a very early, small study (30 participants) testing feasibility in a lab setting. It may not lead to real-world improvements or work for all types of vision loss.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORTICAL BLINDNESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cortical blindness Hemianopsia Hemorrhagic Stroke intracerebral hemorrhage ischemic stroke posterior cerebral artery infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMIANOPIA HOMONYMOUS HEMIANOPSIA OCCIPITAL LOBE INFARCT QUADRANTANOPIA STROKE HEMORRHAGIC STROKE, ISCHEMIC VISION LOSS PARTIAL VISUAL FIELD DEFECT, PERIPHERAL

Contacts and locations

Locations

University of Rochester Medical Center

Rochester, New York, 14642, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.